In Cav-1 knockout mice, metabolic dysfunctions are intensified, indicating that genetic variations in Cav-1 may act as biomarkers for the early identification and management of insulin resistance and metabolic disorders. This evidence concerns the gene CAV1 and Other metabolic disease.